- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.07. | Stereotaxis announces $12.5M offering | ||
| 18.07. | Nuwellis ends clinical trial of its ultrafiltration tech for heart failure | ||
| 18.07. | NanoVibronix enters into $50M financing agreement | ||
| 18.07. | FDA says UroMems can conduct study of smart implant for male stress urinary incontinence | ||
| 17.07. | Exactech names new chief medical officer | ||
| 17.07. | Philips launches ECG AI marketplace | ||
| 17.07. | Paradromics adds new investigator as BCI trial moves toward launch | ||
| 17.07. | Xeltis reports positive data for coronary bypass conduit | ||
| 17.07. | Saluda launches next-gen sensing technology for neuromod | ||
| 17.07. | Abbott posts Q2 beat, lowers high end of guidance | ||
| 16.07. | Imperative Care has positive stroke treatment study results | ||
| 16.07. | Medtronic enrolls first patient in study for Onyx liquid embolic system | ||
| 16.07. | Intuitive demonstrates remote telesurgery capabilities with da Vinci 5 | ||
| 16.07. | BD issues voluntary recall on certain Alaris infusion pump modules | ||
| 16.07. | CVRx announces Medicare win for Barostim therapy | ||
| 16.07. | Proximie, HistoSonics partner on cloud-based tech for liver histotripsy | ||
| 16.07. | Globus Medical expands Excelsius navigation capabilities | ||
| 16.07. | Johnson & Johnson MedTech sales rise 7.3% in Q2 beat, company ups 2025 guidance | ||
| 15.07. | Neuronetics names Steven Pfanstiel chief financial officer | ||
| 15.07. | Medtronic to distribute Future Medical's peripheral guidewires | ||
| 15.07. | AtriCure completes enrollment in stroke prevention trial | ||
| 15.07. | GT Medical raises $53M to support brain tumor treatment | ||
| 15.07. | Imperative Care, Proximie partner to develop surgical robot to treat stroke | ||
| 15.07. | Carlsmed launches IPO roadshow | ||
| 15.07. | Varian introduces IntelliBlate for image-guided cancer therapy in Europe |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .